1
|
Fernandez-Sojo J, Cid J, Pello OM, Martínez-Muñoz ME, Codinach M, Fonseca-Santos M, Santos S, Eguizabal C, Linares M, Castillo-Flores N, Azqueta C, Valvidia E, Larrea L. A survey of cell processing practices for hematopoietic cell transplantation. Cytotherapy 2025; 27:508-515. [PMID: 39891635 DOI: 10.1016/j.jcyt.2024.12.011] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/24/2024] [Revised: 12/21/2024] [Accepted: 12/22/2024] [Indexed: 02/03/2025]
Abstract
BACKGROUND There is considerable heterogeneity in cell handling practices for hematopoietic stem cell transplantation in cell processing centers in Spain. The European Directorate for the Quality of Medicines and international standards are not intended to establish best practices or to include all procedures; therefore, each cell processing laboratory must define its own practices and procedures. METHODS A survey was conducted to better understand the differences among cell processing laboratories in Spain in terms of type of facilities and equipment available, service portfolio, staff, informatics systems, product handling, environmental and product quality control tests, batch release criteria, storage and shipping conditions, and criteria for product disposal or recall, to identify areas for harmonization. RESULTS In this study, 31 authorized centers responded to the survey. Fifteen centers do not usually wash cryopreserved grafts, in contrast to others that perform washing systematically (n = 5) or when the product contains >1 g/kg/dimethyl sulfoxide or recipient body weight is <25 kg (n = 11). We observed high variability in terms of handling of thawed samples, such as in protocols used to enumerate CD34+ cells, compensation solution, temperature and time delay between thawing and CD34+ enumeration. Storage time for cell therapy products varied between 5 and 30 years. Additionally, 12 centers do not reduce plasma before cryopreservation to save space. DISCUSSION Overall, this survey demonstrates variability in activity, logistics and staff among cell processing laboratories in Spain. Some issues remain ongoing and further efforts should be undertaken to harmonize practices in these facilities, such as indications and procedures for washing cryopreserved stem cells and handling of cryovials to enumerate viable CD34+ cells after thawing. Efforts are needed to regulate product storage to optimize space utilization and reduce associated costs.
Collapse
Affiliation(s)
- Jesus Fernandez-Sojo
- Servei de Teràpia Celular, Banc de Sang i Teixits, Barcelona, Spain; Grup de Medicina Transfusional, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
| | - Joan Cid
- Department of Hemotherapy and Hemostasis, Apheresis and Cellular Therapy Unit, Hematopoietic Cell Bank, ICAMS, Clínic Barcelona, IDIBAPS, University of Barcelona, Barcelona, Spain
| | - Oscar M Pello
- Advanced Therapies Unit, Blood and Tissue Bank of Cantabria, Marqués de Valdecilla Foundation, Hematologic Neoplasms and Hematopoietic Stem Cells Transplantation Group - Marqués de Valdecilla Research Institute (IDIVAL), Santander, Spain
| | - María E Martínez-Muñoz
- Department of Hematology and GMP Cellular Therapy Unit, Hospital Universitario Puerta de Hierro Majadahonda and Instituto de Investigación Sanitaria Puerta de Hierro Segovia Arana (IDIPHISA), Madrid, Spain
| | - Margarita Codinach
- Laboratori Cel·lular, Banc de Sang i Teixits, Barcelona, Spain; Grup de Medicina Transfusional, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Hospital Universitari, Barcelona, Spain
| | - Marta Fonseca-Santos
- Department of Hematology, Hospital Universitario de Salamanca, IBSAL, CIBERONC, Centro de Investigación del Cáncer-IBMCC (USAL-CSIC), Salamanca, Spain
| | - Silvia Santos
- Advanced Therapies Unit, Basque Center for Blood Transfusion and Human Tissues, Galdakao, Spain; Cord Blood Bank, Basque Center for Blood Transfusion and Human Tissues, Galdakao, Spain; Cell Therapy, Stem Cells and Tissues Group, Biobizkaia Health Research Institute, Barakaldo, Spain
| | - Cristina Eguizabal
- Advanced Therapies Unit, Basque Center for Blood Transfusion and Human Tissues, Galdakao, Spain; Cell Therapy, Stem Cells and Tissues Group, Biobizkaia Health Research Institute, Barakaldo, Spain
| | - Monica Linares
- Servei de Teràpia Celular, Banc de Sang i Teixits, Barcelona, Spain; Grup de Medicina Transfusional, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain
| | - Nerea Castillo-Flores
- Servei de Teràpia Celular, Banc de Sang i Teixits, Barcelona, Spain; Grup de Medicina Transfusional, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain
| | - Carmen Azqueta
- Servei de Teràpia Celular, Banc de Sang i Teixits, Barcelona, Spain; Grup de Medicina Transfusional, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain
| | - Elena Valvidia
- Servei de Teràpia Celular, Banc de Sang i Teixits, Barcelona, Spain; Grup de Medicina Transfusional, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain
| | - Luis Larrea
- Head of the Processing Department, Centro de Transfusión de la Comunidad Valenciana, Valencia, Spain; Department of Medicine & Surgery, Health Sciences School, Universidad Cardenal Herrera-CEU, CEU Universities, Alfara del Patriarca, Valencia, Spain
| |
Collapse
|